v3.26.1
SEGMENT REPORTING (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Reconciliation of Reported Revenues to Net (Loss) Income Under Significant Expense Principle The following table reconciles reported revenues to net (loss) income under the significant expense principle for the three months ended March 31, 2026 and 2025:
Three Months Ended March 31,
(in millions)
20262025
Revenues:
Product revenue, net51.8 39.4 
Royalties— 0.2 
Total revenues$51.8 $39.6 
Operating expenses:
Cost of goods sold1.7 1.2 
Research and development
Research and clinical expenses13.0 13.7 
Chemistry, manufacturing, and control expenses0.6 1.5 
Restructuring charges(0.2)— 
Selling, general and administrative
Commercial expenses17.0 20.0 
Restructuring charges(0.2)— 
Other segment expenses*19.8 19.9 
Total interest and other income (expense)(3.7)(3.1)
Net loss$(3.6)$(19.8)
    
___________________________
*Other segment expenses includes stock-based compensation expense and other general and administrative expenses largely resulting from personnel costs for individuals in administrative functions and legal and professional fees.